US Patent Issued to Genentech on Jan. 20 for "Methods and compositions for treating systemic lupus erythematosus (SLE) with mosunetuzumab" (California, Washington Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,874, issued on Jan. 20, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Methods and compositions for treating systemic lupus erythematosus (SLE) with mosunetuzumab" was invented by Susan Lee Limb (South San Francisco, Calif.), Matthew Dominic Cascino (Millbrae, Calif.), Monique Nicoll (South San Francisco, Calif.), Jay Prakash Garg (Menlo Park, Calif.) and Michael Zecong Liao (Bellevue, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions and methods for the treatment of systemic lupus erythematosus using anti-CD20/anti-CD3 bispecific antibodies, such as mosunetuzumab."

The patent was filed on Nov. 1...